高级检索
当前位置: 首页 > 详情页

Development and validation of a semi-automatic radiomics ensemble model for preoperative evaluation of breast masses in mammotome-assisted minimally invasive resection

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Sun Yat Sen Univ, Affiliated Hosp 5, Dept Thyroid & Breast Surg, 52 Meihua East Rd, Zhuhai 519000, Peoples R China [2]Wuhan Univ, Wuhan Hosp 3, Tongren Hosp, Dept Proctol, Wuhan, Peoples R China [3]Zunyi Med Univ, Zhuhai Campus, Zhuhai, Peoples R China [4]Sun Yat Sen Univ, Affiliated Hosp 5, Dept Radiol, 52 Meihua East Rd, Zhuhai 519000, Peoples R China
出处:
ISSN:

关键词: Breast lesion ultrasound (US) mammotome radiomics deep learning

摘要:
Background: Accurate preoperative differentiation of breast masses is critical for guiding individualized treatment strategies in Mammotome-assisted minimally invasive resection. While radiomics shows promise, existing methods rely on manual delineation, which is time-consuming and subjective. This study developed an ultrasound-based semi-automatic segmentation ensemble model to improve preoperative assessment. Methods: We retrospectively analyzed preoperative ultrasound images from 773 patients (543 tumors, 230 non-tumors). Semi-automatic segmentation was performed using DeepLabv3_ResNet50 and fully convolutional network (FCN)_ResNet50. Radiomic and deep transfer learning (DTL) features were extracted to construct radiomic, deep learning, and combined models. An ensemble strategy integrated these with clinical models. Performance was evaluated via receiver operating characteristic (ROC) curves and decision curve analysis (DCA). Results: The cohort included 543 tumor patients and 230 non-tumor patients (95 adenosis, 135 other benign lesions). The semi-automatic segmentation model, DeepLabv3_ResNet50, achieved a peak global accuracy of 99.4% and an average Dice coefficient of 92.0% at its best epoch. On the other hand, the FCN_ ResNet50 model exhibited a peak global accuracy of 99.5% and an average Dice coefficient of 93.7% at its best epoch. In the task of predicting tumor and non-tumor patients, age, maximum diameter, and BI-RADS (Breast Imaging Reporting and Data System) classification were ultimately identified as key indicators, and the stacking model ultimately demonstrated an area under the curve (AUC) of 0.890 in the training cohort (with a sensitivity of 0.844 and a specificity of 0.815) and an AUC of 0.780 in the testing cohort (with a sensitivity of 0.713 and a specificity of 0.739). In the task of predicting adenosis and other lesion types, focus emerged as a crucial factor, and the stacking model achieved an AUC of 0.813 in the training cohort (with a sensitivity of 0.613 and a specificity of 0.859) and an AUC of 0.771 in the testing cohort (with a sensitivity of 0.759 and a specificity of 0.765). Conclusions: Our study has established an ensemble learning model grounded in semi-automatic segmentation techniques. This model accurately distinguishes between tumor and non-tumor patients preoperatively, as well as discriminating adenosis from other lesion types among the non-tumor cohort, thus providing valuable insights for individualized treatment planning. The proposed stacking model demonstrates significant clinical utility by reducing unnecessary biopsies and saving diagnostic time compared to manual review. These improvements directly address the challenges of overtreatment and diagnostic delays in breast lesion management. By enhancing preoperative accuracy, our model supports tailored surgical planning and alleviates patient anxiety associated with indeterminate diagnoses.

语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 4 区 医学
小类 | 4 区 外科
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 外科
JCR分区:
出版当年[2023]版:
Q3 SURGERY
最新[2023]版:
Q3 SURGERY

影响因子: 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者:
第一作者机构: [1]Sun Yat Sen Univ, Affiliated Hosp 5, Dept Thyroid & Breast Surg, 52 Meihua East Rd, Zhuhai 519000, Peoples R China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:25477 今日访问量:0 总访问量:1499 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)